Abacus Bioscience, Inc.

Calculating rank

USPTO Granted Patents = 5

Trademarks = 1

Forward Citations = 1

Loading Chart...

5 inventors (with patents filed for the assignee):

Edward A Clark (5 out of 16 patents)

Che-Leung Law (5 out of 5 patents)

Deborah Fuller (5 out of 8 patents)

4. Amanda Mak (3 out of 3 patents)

5. Michael J Gale (2 out of 6 patents)

5 patents: Sort by Forward Citations

1. 12496339 - Therapeutic Vaccine for Hepatitis B Virus (HBV) using the HBV Core Antigen (2025-12-16),

2. 12285482 - Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS2, and/or S-HBsAg regions of the HBV envelope protein (2025-04-29),

3. 11883488 - Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen (2024-01-30),

4. 11389532 - Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS2, and/or s-HBsAg regions of the HBV envelope protein (2022-07-19),

5. 11324819 - Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen (2022-05-10),

Company Overview

Abacus Bioscience, Inc. is a leading biotechnology company specializing in the development of innovative diagnostic solutions for the healthcare industry. With a strong focus on precision medicine, our cutting-edge technologies provide accurate and reliable information to healthcare professionals, leading to better patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#5 in Sammamish, WA

#1,242 in Washington

#51,669 in US

Sammamish, WA, United States of America